Cargando…

Chronic pain in Gaucher disease: skeletal or neuropathic origin?

BACKGOUND: Pain is one of the most disabling symptoms of Gaucher disease. It is referred by the majority of Gaucher patients and often persists despite long-term enzyme replacement treatment. It has been mainly considered as nociceptive pain secondary to skeletal involvement but it is described even...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devigili, Grazia, De Filippo, Michele, Ciana, Giovanni, Dardis, Andrea, Lettieri, Christian, Rinaldo, Sara, Macor, Daniela, Moro, Alessandro, Eleopra, Roberto, Bembi, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580212/ https://www.ncbi.nlm.nih.gov/pubmed/28859662 http://dx.doi.org/10.1186/s13023-017-0700-7

Ejemplares similares

Profile of eliglustat tartrate in the management of Gaucher disease
por: Sechi, Annalisa, et al.
Publicado: (2016)

Chronic post-traumatic neuropathic pain of brachial plexus and upper limb: a new technique of peripheral nerve stimulation
por: Stevanato, Giorgio, et al.
Publicado: (2014)

Eye Movement Impairment Recovery in a Gaucher Patient Treated with Miglustat
por: Accardo, Agostino, et al.
Publicado: (2010)

In vitro and in vivo effects of Ambroxol chaperone therapy in two Italian patients affected by neuronopathic Gaucher disease and epilepsy
por: Ciana, Giovanni, et al.
Publicado: (2020)

Lessons from the present: Intraoperative neurophysiological monitoring organization during the COVID-19 pandemic in Lombardy, northern Italy
por: Devigili, Grazia, et al.
Publicado: (2020)

AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study
por: Eleopra, Roberto, et al.
Publicado: (2018)

Globus Pallidus Internus Deep Brain Stimulation Using Frame-Based vs. Frameless Stereotaxy in Dystonia: A Single-Center Experience
por: Eleopra, Roberto, et al.
Publicado: (2021)

Accurate Molecular Diagnosis of Gaucher Disease Using Clinical Exome Sequencing as a First-Tier Test
por: Zampieri, Stefania, et al.
Publicado: (2021)

Diagnostic criteria for small fibre neuropathy in clinical practice and research
por: Devigili, Grazia, et al.
Publicado: (2019)

Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease
por: Wei, Jianshe, et al.
Publicado: (2021)

Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)
por: Zimran, Ari, et al.
Publicado: (2017)

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
por: Liu, Ganqiang, et al.
Publicado: (2016)

CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020)

Exercise training alone or in combination with high-protein diet in patients with late onset Pompe disease: results of a cross over study
por: Sechi, Annalisa, et al.
Publicado: (2020)

Myocardial fibrosis as the first sign of cardiac involvement in a male patient with Fabry disease: report of a clinical case and discussion on the utility of the magnetic resonance in Fabry pathology
por: Sechi, Annalisa, et al.
Publicado: (2014)

Glycogen Reduction in Myotubes of Late-Onset Pompe Disease Patients Using Antisense Technology
por: Goina, Elisa, et al.
Publicado: (2017)

Focal hepatic lesions in acid sphingomyelinase deficiency: Differential diagnosis between foamy macrophages aggregates and malignancy
por: Sechi, Annalisa, et al.
Publicado: (2021)

Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease
por: Ivanova, Margarita M., et al.
Publicado: (2021)

Gaucher Disease and Gaucher Cells
por: Gözdaşoğlu, Sevgi
Publicado: (2015)

Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease
por: Maas, M., et al.
Publicado: (2008)

Presenting signs and patient co‐variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED‐C) Delphi initiative
por: Mehta, Atul, et al.
Publicado: (2019)

Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1
por: Dardis, A., et al.
Publicado: (2022)

Characterization of a Spontaneous Novel Mutation in the NPC2 Gene in a Cat Affected by Niemann Pick Type C Disease
por: Zampieri, Stefania, et al.
Publicado: (2014)

Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish
por: Artola, Marta, et al.
Publicado: (2019)

The Neuropathic Origin of Edema
Publicado: (1889)

Gaucher Cells or Pseudo-Gaucher Cells: That’s the Question
por: Gören Şahin, Deniz, et al.
Publicado: (2014)

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism
por: Furderer, Makaila L., et al.
Publicado: (2022)

A human neuronal model of Niemann Pick C disease developed from stem cells isolated from patient’s skin
por: Bergamin, Natascha, et al.
Publicado: (2013)

Unraveling Autonomic Dysfunction in GBA‐Related Parkinson's Disease
por: Devigili, Grazia, et al.
Publicado: (2023)

Gaucher's disease
por: Bohra, Vijay, et al.
Publicado: (2011)

Gaucher’s Disease
Publicado: (1916)

Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry
por: Rosenbloom, Barry E., et al.
Publicado: (2022)

Relief of nocturnal neuropathic pain with the use of cannabis in a patient with Fabry disease
por: Bon, Martina, et al.
Publicado: (2023)

Skeletal involvement in Gaucher disease: extent of bone disease, splenic volume, and quality of life
por: de Mello, Ricardo Andrade Fernandes, et al.
Publicado: (2021)

Promising Effect of High Dose Ambroxol Treatment on Neurocognition and Motor Development in a Patient With Neuropathic Gaucher Disease 2
por: Aries, Charlotte, et al.
Publicado: (2022)

Clinical Outcomes of Patients with Chronic Neuropathic Form of Gaucher Disease in the Spanish Real-World Setting: A Retrospective Study
por: Stanescu, Sinziana, et al.
Publicado: (2023)

Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone
por: Zampieri, Stefania, et al.
Publicado: (2009)

Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry
por: Nguyen, Yann, et al.
Publicado: (2020)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

Gaucher-Associated Parkinsonism
por: Li, Yaqiong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_riov2g7mna44qbl757melvde8n